Clinical trial

Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and…

NCT00333437 · University of California, San Francisco, Other · Completed

Key facts

NCT number NCT00333437
Title Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
Official title Pulmonary Involvement in Scleroderma: Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients
Lead sponsor University of California, San Francisco, Other
Collaborators Roche Pharma AG Industry
Status Completed
Study type Interventional
Conditions Scleroderma, Systemic
Intervention type Drug
Interventions Mycophenolate mofetil
Enrollment 7
Start date May 1, 2006
Primary completion Jan 1, 2009
Completion Jan 1, 2009
First posted Jun 5, 2006
Last update posted Nov 13, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies